Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA)

74 filings reported holding TARA - Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Protara Therapeutics, Inc. - Common Stock, par value $0.001 per share (TARA) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28.8M shares of 40.2M outstanding shares and own 71.47% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (3.79M shares), RA CAPITAL MANAGEMENT, L.P. (3.4M shares), Blackstone Inc. (1.74M shares), Opaleye Management Inc. (1.73M shares), Velan Capital Investment Management LP (1.67M shares), VANGUARD GROUP INC (1.6M shares), Sio Capital Management, LLC (1.51M shares), Integral Health Asset Management, LLC (1.4M shares), ACORN CAPITAL ADVISORS, LLC (1.28M shares), and STEMPOINT CAPITAL LP (1.19M shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.